CABHI is working with RetiSpec to accelerate its technology in Ontario and Canada

The CABHI-funded RetiSpec trial will determine the safety and effectiveness of the technology through human clinical testing, and help spur commercialization of the technology in Ontario and Canada – to get it into the hands of those who need it most.


1 view0 comments